September 26, 2024 – CDC DTBE and APHL released a new DCL with updated information about the availability of PZA test kits. Public health laboratories (PHL) are encouraged to evaluate these new kits as they are received. Recognizing it may require additional time before PZA susceptibility is reinstated, pncA sequencing of Mycobacterium tuberculosis complex can still be accessed using the CDC TB laboratory and other non-CDC laboratories. Read the DCL.
September 11, 2024 – NTCA President, Jason Cummins (TN), prepared a letter to our membership to acknowledge your dedicated work as public health professionals in the field of tuberculosis and express hope for what we can achieve together in the 30th year of NTCA’s work as an organization. Read it here.
August 19, 2024 – ASTHO just released a new blog on the importance of partnerships as we work to address our ongoing TB drug availability challenges. Partnering to Increase Access to Tuberculosis Medications is now available.
August 7, 2024 – CDC DTBE and APHL released a DCL, Notification of expanded capacity for pncA sequencing for evaluating PZA susceptibility, which provides a plan for requesting pncA sequencing. Access the DCL here. This DCL is the second released by CDC DTBE on the PZA susceptibility testing challenges. The initial one, released on 7/25/24, is also available here.
